Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Intersect Ent Inc (XENT)

Intersect Ent Inc (XENT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Intersect Ent Inc 1555 ADAMS DRIVE MENLO PARK CA 94025 USA

www.intersectent.com P: 650-641-2100 F: 650-641-2120

Sector:

Medical

INDUSTRY GROUPING:

Medical Instruments

Description:

Intersect ENT, Inc. is a commercial drug-device company. The Company's initial products, PROPEL and PROPEL mini, are drug-eluting implants for use in patients with chronic sinusitis. It offers products and therapies for ear, nose, and throat surgeons to improve treatment for their patients with chronic diseases. Intersect ENT, Inc. is headquartered in Menlo Park, California.

Key Statistics

Overview:

Market Capitalization, $K 954,907
Shares Outstanding, K 33,814
Float, K 32,631
% Float 96.50%
% of Insider Shareholders 3.50%
% of Institutional Shareholders 92.47%

Financials:

Annual Sales, $ 106,750 K
Annual Net Income, $ -159,640 K
Last Quarter Sales, $ 21,580 K
Last Quarter Net Income, $ -28,800 K

Growth:

1-Year Return 60.27%
3-Year Return 9.41%
5-Year Return 24.13%
5-Year Revenue Growth 35.62%
5-Year Earnings Growth -210.11%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.70 on 03/08/22
Next Earnings Date 05/16/22
Earnings Per Share ttm -1.67
EPS Growth vs. Prev Qtr -45.83%
EPS Growth vs. Prev Year -29.63%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

XENT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -709.52%
Return-on-Assets % -48.18%
Profit Margin % -149.55%
Debt/Equity -1.52
Price/Sales 8.95
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -2.78
Interest Coverage -24.05
60-Month Beta 1.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar